Literature DB >> 8977100

Uroguanylin gene expression in the alimentary tract and extra-gastrointestinal tissues.

M Miyazato1, M Nakazato, S Matsukura, K Kangawa, H Matsuo.   

Abstract

Uroguanylin, a member of the guanylin peptide family, is a novel peptide regulator for intestinal salt and water transport. A cDNA encoding a precursor for rat uroguanylin was cloned from a rat jejunum cDNA library and sequenced. The precursor was 106 amino acids long and included a 21 residue putative signal peptide at the N-terminus. Rat uroguanylin consisted of 15 amino acids similar to, but distinct from human uroguanylin; the C-terminal leucine residue was deleted and 3 residues were substituted compared to those in the human peptide. Synthetic rat uroguanylin-15 dose-dependently increased the cyclic GMP level in cultured T84 cells. RNA blot analysis showed that rat uroguanylin mRNA is expressed not only in the gastrointestinal tract but also in the lung, pancreas and kidney. Evidence for uroguanylin expression in extra-gastrointestinal tissues indicates the possible existence of a novel system for water and electrolyte homeostasis, and a more global effect of uroguanylin on epithelial cell function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977100     DOI: 10.1016/s0014-5793(96)01235-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Expression of guanylin in "pars tuberalis-specific cells" and gonadotrophs of rat adenohypophysis.

Authors:  L D'Este; H Kulaksiz; U Rausch; R Vaccaro; T Wenger; Y Tokunaga; T G Renda; Y Cetin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Guanylin and functional coupling proteins in the hepatobiliary system of rat and guinea pig.

Authors:  Karen Schwabe; Yalcin Cetin
Journal:  Histochem Cell Biol       Date:  2012-02-07       Impact factor: 4.304

3.  Guanylin-immunoreactive cells in the female and male rat adenohypophysis and their changes under various physiological and experimental conditions.

Authors:  Loredana D'Este; Arianna Casini; Yalcin Cetin; Tibor Wenger; Tindaro G Renda
Journal:  Histochem Cell Biol       Date:  2005-04-06       Impact factor: 4.304

4.  Uroguanylin levels in intestine and plasma are regulated by nutritional status in a leptin-dependent manner.

Authors:  C Folgueira; E Sanchez-Rebordelo; S Barja-Fernandez; R Leis; S Tovar; F F Casanueva; C Dieguez; R Nogueiras; L M Seoane
Journal:  Eur J Nutr       Date:  2015-03-06       Impact factor: 5.614

Review 5.  Mechanisms of actions of guanylin peptides in the kidney.

Authors:  Aleksandra Sindić; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2005-06-11       Impact factor: 3.657

6.  The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor).

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Bonnie Taylor-Blake; Michael F Goy
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-24

Review 7.  Pendrin, a novel transcriptional target of the uroguanylin system.

Authors:  Julia Rozenfeld; Osnat Tal; Orly Kladnitsky; Lior Adler; Edna Efrati; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2013-12-18

8.  Occurrence and localization of uroguanylin in the aging human prostate.

Authors:  Caroline Maake; Franziska Auf der Maur; Katarina Jovanovic; Manfred Reinecke; Dieter Hauri; Hubert John
Journal:  Histochem Cell Biol       Date:  2002-12-21       Impact factor: 4.304

9.  Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules.

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

10.  Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

Authors:  Nicholas G Moss; Robert C Fellner; Xun Qian; Sharon J Yu; Zhiping Li; Masamitsu Nakazato; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.